Undertreatment of osteoporosis following hip fracture in the elderly

Archives of Gerontology and Geriatrics

Volumn 49, Issue 1, 2009, Pages 153-157

  Lüthje, Peter ^a   Nurmi Lüthje, Ilona ^b,c   Kaukonen, Juha Pekka ^d   Kuurne, Salla ^a   Naboulsi, Helena ^d   Kataja, Matti ^e  

^a Kuusankosken Aluesairaala   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Center for Injury and Violence Prevention   (Finland)

^d PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Adherence for prescribed osteoporosis treatment; Anti osteoporotic treatment; Hip fracture; Osteoporosis

Indexed keywords

CALCIUM; VITAMIN D;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HIP FRACTURE; HUMAN; LOCOMOTION; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRESCRIPTION; PRIORITY JOURNAL; SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; CALCIUM; FEMALE; FINLAND; FOLLOW-UP STUDIES; HIP FRACTURES; HUMANS; MALE; OSTEOPOROSIS; PREVALENCE; VITAMIN D;

EID: 67349200769     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2008.06.007     Document Type: Article

References (57)

1. AAOS (American Academy of Orthopedic Surgeon). Position Statement. Hip Fracture in Seniors: A Call for Health System Reform (1999), American Academy of Orthopedic Surgeons, Rosemont
2. Berry S.D., Samelson E.J., Hannan M.T., McLellan R.R., Lu M., Cupples L.A., Shaffer M.L., Beiser A.L., Kelly-Hayes M., and Kiel D.P. Second hip fracture in older men and women. Arch. Int. Med. 167 (2007) 1971-1976
3. Black D.M., Steinbuch M., Palermo L., Dargent-Molina P., Lindsay R., Hoseyni M.S., and Johnell O. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporosis Int. 12 (2001) 519-528
4. Black D.M., Delmas P.D., Eastell R., Reid I.R., Boonen S., Cauley J.A., Cosman F., Lakatos P., Leung P.C., Man Z., Mautalen C., Mesenbrink P., Hu H., Caminis J., Tong K., Rosario-Jansen T., Krasnow J., Hue T.F., Sellmeyer D., Eriksen E.F., and Cummings S.R. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N. Engl. J. Med. 356 (2007) 1809-1822
5. Boonen S., McClung M.R., Eastell R., El-Hajj Fuleihan G., Barton I.P., and Delmas P. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J. Am. Geriatr. Soc. 52 (2004) 1832-1839
6. Cadarette S.M., Katz J.N., Brookhart M.A., Levin R., Stedman M.R., Choudhry N.K., and Solomon D.H. Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J. Rheumatol. 35 (2008) 319-326
7. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., and Meunier P.J. Prevalence of vitamin D insufficiency in adult normal population. Osteoporosis Int. 7 (1997) 439-443
8. Classification of Drugs, 2006. Lääkkeiden luokitus (ATC) ja määritellyt vuoro-kausiannokset (DDD). Lääkelaitos, Edita Prima Oy (in Finnish).
9. Colón-Emeric C., Kuchibhatla M., Pieper C., Hawkes W., Fredman L., Magaziner J., Zimmerman S., and Lyles K.W. The contribution of hip fracture to risk of subsequent fracture: data from two longitudinal studies. Osteoporosis Int. 14 (2003) 879-883
10. Cramer J., Amonkar M.M., Hebborn A., and Suppapanya N. Does dosing regimen impact persistence with bisphosphonate therapy among postmeno-pausal osteoporotic women?. J. Bone Miner. Res. 19 Suppl. 1 (2004) S448
11. Dinah A.F. Sequential hip fractures in elderly patients. Injury 33 (2002) 393-394
12. Dirschl D.R., Henderson R.C., and Oakley W.C. Accelerated bone mineral loss following a hip fracture: a prospective longitudinal study. Bone 21 (1997) 79-82
13. Dretakis K.E., Dretakis E.K., Papakitsou E.F., Psarakis S., and Steriopoulus K. Possible predisposing factors for the second hip fracture. Calcif. Tissue Int. 62 (1998) 366-369
14. Fox K.M., Magaziner J., Hawkes W.G., Yo-Yahiro J., Zimmerman S.I., Holder L., and Michael R. Loss of bone density and lean body mass after hip fracture. Osteoporosis Int. 11 (2000) 31-35
15. Fukushima T., Sudo A., and Uchida A. Bilateral hip fractures. J. Orthop. Sci. 11 (2006) 435-438
16. Gardner M.J., Flik K.R., Moor P., and Lane J.M. Improvement in the under-treatment of osteoporosis following hip fracture. J. Bone Joint Surg. Am. 84 (2002) 1342-1348
17. Haynes R.B., Yao X., Degani A., Kripalani S., Garg A., and McDonald H.P. Interventions for enhancing medication adherence (review). Cochrane Libr. (2006) 4
18. Heikkinen T., Willig R., Hänninen A., Koskinen K., Mannismäki P., Alavaikko A., von und zu Fraunberg M., and Jalovaara P. Hip fractures in Finland-a comparison of patient characteristics and outcomes in six hospitals. Scand. J. Surg. 93 (2004) 234-240
19. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 79 (2004) 362-371
20. Johnell O., Jonsson B., Jonsson L., and Black D. Cost effectiveness of alendronate for the treatment of osteoporosis and prevention of fractures. Pharmacoeconomics 21 (2003) 305-314
21. Johnell O., Kanis J.A., Oden A., Sernbo I., Redlund-Johnell I., Petterson C., De Laet C., and Jönsson B. Fracture risk following an osteoporotic fracture. Osteoporosis Int. 15 (2004) 175-179
22. Juby A.G., and Degeus-Wenceslau C.M. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporosis Int. 13 (2002) 205-210
23. Järvinen T.L.N., Sievänen H., Khan K.M., Heinonen A., and Kannus P. Shifting the focus in fracture prevention from osteoporosis to falls. Br. Med. J. 336 (2008) 124-126
24. Kamel H.K. Secondary prevention of hip fractures among the hospitalized elderly: are we doing enough?. J. Clin. Rheumatol. 11 (2005) 68-71
25. Kamel H.K., Hussain M.S., Tariq S., Perry H.M., and Morley J.E. Failure of diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am. J. Med. 109 (2000) 326-328
26. Kanis J.A., Delmas P., Burckhardt P., Cooper C., and Torgerson D. Guidelines for diagnosis and management of osteoporosis. The European foundation for osteoporosis and bone disease. Osteoporosis Int. 7 (1997) 390-406
27. Kanis J.A., Borgström F., Johnell O., and Jonsson B. Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women. Osteoporosis Int. 15 (2004) 862-871
28. Kanis J.A., Adams J., Borgström F., Cooper C., Jönsson B., Preedy D., Selby P., and Compston J. The cost-effectiveness of alendronate in the management of osteoporosis. Bone 42 (2008) 4-15
29. Kannus P., Niemi S., Parkkari J., Palvanen M., Heinonen A., Sievänen H., Järvinen T., Khan K., and Järvinen M. Why is the age-standardized incidence of low-trauma fractures rising in many elderly population?. J. Bone Miner. Res. 17 (2002) 1363-1367
30. Kannus P., Sievänen H., Palvanen M., Järvinen T., and Parkkari J. Prevention of falls and consequent injuries in elderly people. Lancet 366 (2005) 1885-1893
31. Karlsson M., Nilsson J.A., Sernbo I., Redlund-Johnell I., Johnell O., and Obrant K.J. Changes of bone mineral mass and soft tissue composition after hip fracture. Bone 18 (1996) 19-22
32. Khandwala H.M., Kolla N., and Grover V.K. Evaluation and treatment of osteoporosis in patients with a fragility hip fracture. Endocr. Pract. 11 (2005) 370-375
33. Knopp J.A., Diner B.M., Blitz M., Lyritis G.P., and Rowe B.H. Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporosis Int. 16 (2005) 1281-1290
34. Lussier D., Huskey A.G., and Portenoy R.K. Adjuvant analgesics in cancer pain management. Oncologist 9 (2004) 571-591
35. Lyles K.W., Colón-Emeric C.S., Magaziner J.S., Adachi J.D., Pieper C.F., Mautalen C., Hyldstrup L., Recknor C., Nordsletten L., Moore K.A., Lavecchia C., Zhang J., Mesenbrink P., Hodgson P.K., Abrams K., Orloff J.J., Horowitz Z., Eriksen E.F., and Boonen S. HORIZON recurrent fracture trial. Zoledronic acid and clinical fractures and mortality after hip fracture. N. Engl. J. Med. 357 (2007) 1799-1809
36. Lönnroos E., Kautiainen H., Karppi P., Hartikainen S., Kiviranta L., and Sulkava R. Incidence of second hip fracture. A population-based study. Osteoporosis Int. 18 (2007) 1279-1285
37. McLellan A.R., Gallacher S.J., Fraser M., and McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporosis Int. 14 (2003) 1028-1034
38. National Guidelines, 2006a. Treatment of hip fracture patients. Duodecim 122, 358-379, http://www.kaypahoito.fi (in Finnish).
39. National Guidelines, 2006b. Osteoporosis. Duodecim 123, 1-24, http://www.kaypahoito.fi (in Finnish).
40. NIH Consensus Development Panel, 2001. Osteoporosis prevention, diagnosis, and therapy. J. Am. Med. Assoc. 285, 785-795.
41. Nurmi I., Narinen A., Lüthje P., and Tanninen S. Functional outcome and survival after hip fracture in elderly: a prospective study of 106 consecutive patients. J. Orthopaed. Traumatol. 4 (2004) 7-14
42. Nurmi I., Kaukonen J.-P., Lüthje P., Naboulsi H., Tanninen S., Kataja M., Kallio M.-L., and Leppilampi M. Half of the patients with an acute hip fracture suffer from hypovitaminosis D: a prospective study in southeastern Finland. Osteoporosis Int. 16 (2005) 2018-2024
43. Oliver D., Connelly J.B., Victor C.R., Shaw F.E., Whitehead A., Genc Y., Vanoli A., Martin F.C., and Gosney M.A. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. Br. Med. J. 334 (2007) 82 -Epub 2006
44. Panneman M.J.M., Lips P., Sen S.S., and Herings R.M.C. Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporosis Int. 15 (2004) 120-124
45. Papadokostakis G., Damilakis J., Mantzouranis E., Katonis P., and Hadjipavlou A. The effectiveness of calcitonin on chronic back pain and daily activities in postmenopausal women with osteoporosis. Eur. Spine J. 15 (2006) 356-362
46. Papaioannou A., Ioannidis G., Adachi J.D., Sebaldt R.J., Ferko N., Puglia M., Brown J., Tenenhouse A., Olszynski W.P., Boulos P., Hawley D.A., Josse R., Murray T.M., Petrie A., and Goldsmith C.H. Adherence to bisphos-phonate and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporosis Int. 14 (2003) 808-813
47. Petrella, R.P., Jones, T.J., 2006. Do patients receive recommended treatment of osteoporosis following hip fracture in primary care? BMC Family Practice 7, 31; http://www.biomedcentral.com/1471-2296/7/31; Epub: doi:10.1186/1471-2296-7-31.
48. Poole K.E., and Compston J.E. Osteoporosis and its management. Br. Med. J. 333 (2006) 1251-1256
49. Reginster J.Y., and Rabenda V. Adherence to anti-osteoporotic treatment: does it really matter?. Future Rheumatol. 1 (2006) 37-40
50. Robinovitch S.N., Inkster L., Maurer J., and Warnick B. Strategies for avoiding hip impact during sideways falls. J. Bone Miner. Res. 18 (2003) 1267-1273
51. Rodaro E., Pasqualini M., Iona L.G., and Di Benedetto P. Functional recovery following a second hip fracture. Eura Medicophys. 40 (2004) 179-183
52. Schousboe J.T., Ensrud K.E., Nyman J.A., Melton III L.J., and Kane R.L. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J. Am. Geriatr. Soc. 53 (2005) 1697-1704
53. Schousboe J.T., Nyman J.A., Kane R.L., and Ensrud K.E. Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann. Int. Med. 142 (2005) 734-741
54. Van Helden S., Cals J., Kessels F., Brink P., Dinant G.J., and Geusens P. Risk of new clinical fractures within 2 years following a fracture. Osteoporosis Int. 17 (2006) 348-354
55. Van Helden S., Van Geel A.C., Geusens P.P., Kessels A., Nieuwenhuijzen Kruseman A.C., and Brink P.R. Bone and fall-related fracture risks in women and men with a recent clinical fracture. J. Bone Joint Surg. Am. 90 (2008) 241-248
56. Woo T., and Adachi J.A. Role of bisphophonates and calcitonin in the prevention and treatment of osteoporosis. Best Pract. Res. Clin. Rheumatol. 15 (2001) 469-481
57. Yamanashi A., Yamazaki K., Kanamori M., Mochizuki K., Okamoto S., Koide Y., Kin K., and Nagano A. Assessment of risk factors for second hip fractures in Japanese. Osteoporosis Int. 16 (2005) 1239-1246